Alerte Ou Avis De Sécurité sur All Accu-Chek® Insight insulin pumps

Selon Medicines and Healthcare products Regulatory Agency, ce/cet/cette alerte ou avis de sécurité concerne un dispositif en/au/aux/à United Kingdom qui a été fabriqué par Roche Diabetes Care.

Qu'est-ce que c'est?

Les avis de sécurité sont des communications que les fabricants de dispositifs médicaux ou leurs représentants font parvenir en particulier aux travailleurs du secteur médical, mais aussi aux utilisateurs de ces dispositifs. Les avis de sécurité concernent les actions entreprises quant aux dispositifs présents sur le marché et peuvent inclure des rappels et des alertes.

En savoir plus sur les données ici
  • Type d'événement
    Safety alert / Field Safety Notice
  • Date
    2017-05-02
  • Date de publication de l'événement
    2017-05-02
  • Pays de l'événement
  • Source de l'événement
    MHRA
  • URL de la source de l'événement
  • Notes / Alertes
    Data from the United Kingdom is current through April 2019. All of the data comes from the Medicines and Healthcare products Regulatory Agency, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and the United Kingdom.
  • Notes supplémentaires dans les données
    Note that this alert replaces and updates MDA/2015/029 which we published in August 2015.Roche has provided updated handling instructions and frequency for battery change to every 14 days from the 30 days previously recommended.
  • Cause
    Manufactured by roche diabetes care – replacement and update to mda/2015/029 with new instructions to improve battery lifetime and prevent unexpected pump shut down or rapid battery depletion.
  • Action
    Identify all users of Accu-Chek Insight insulin pumps. Ensure that all patients and carers: Receive the manufacturer’s Field Safety Notice (FSN) understand the problem detailed in the FSN and follow the advice given by the manufacturer use Energizer® Ultimate lithium batteries (1.5V AAA / FR03) provided by the manufacturer and follow the steps described in the handling instructions in the FSN Contact Roche if you experience unexpected pump shut down or rapid battery depletion. Return the FSN acknowledgment form to Roche as currently the manufacturer hasn’t received enough responses.

Device

Manufacturer

  • Adresse du fabricant
    Roche Diabetes CareTel: 0800 731 2291burgesshill.insulinpumps@roche.comManufacturer FSCA Reference: SB_RDC_2017_04
  • Société-mère du fabricant (2017)
  • Source
    MHRA